期刊
JOURNAL OF INFLAMMATION-LONDON
卷 18, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12950-021-00269-5
关键词
Melatonin; Angiogenesis; Cardiovascular disease; Regeneration
类别
资金
- Tabriz University of Medical Sciences [IR.TBZMED.VCR.REC.1398.160]
Melatonin has multi-organ and pleiotropic effects in controlling angiogenesis at the molecular and cellular levels. Angiogenesis, the development of new blood vessels from pre-existing ones, is dependent on the balance of pro- and anti-angiogenic factors. Accelerating angiogenesis is seen as an effective strategy in healing ischemic changes like infarcted myocardium.
Melatonin possesses multi-organ and pleiotropic effects with potency to control angiogenesis at both molecular and cellular levels. To date, many efforts have been made to control and regulate the dynamic of angiogenesis modulators in a different milieu. The term angiogenesis or neovascularization refers to the development of de novo vascular buds from the pre-existing blood vessels. This phenomenon is tightly dependent on the balance between the pro- and anti-angiogenesis factors which alters the functional behavior of vascular cells. The promotion of angiogenesis is thought to be an effective strategy to accelerate the healing process of ischemic changes such as infarcted myocardium. Of note, most of the previous studies have focused on the anti-angiogenesis capacity of melatonin in the tumor niche. To the best of our knowledge, few experiments highlighted the melatonin angiogenesis potential and specific regulatory mechanisms in the cardiovascular system. Here, we aimed to summarize some previous experiments related to the application of melatonin in cardiovascular diseases such as ischemic injury and hypertension by focusing on the regulatory mechanisms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据